These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 24613739

  • 1. Class II versus Class III radical hysterectomy in early cervical cancer: an observational study in a tertiary center.
    Ditto A, Martinelli F, Ramondino S, Vullo SL, Carcangiu M, Haeusler E, Mariani L, Lorusso D, Raspagliesi F.
    Eur J Surg Oncol; 2014 Jul; 40(7):883-90. PubMed ID: 24613739
    [Abstract] [Full Text] [Related]

  • 2. Class III nerve-sparing radical hysterectomy versus standard class III radical hysterectomy: an observational study.
    Ditto A, Martinelli F, Mattana F, Reato C, Solima E, Carcangiu M, Haeusler E, Mariani L, Raspagliesi F.
    Ann Surg Oncol; 2011 Nov; 18(12):3469-78. PubMed ID: 21556949
    [Abstract] [Full Text] [Related]

  • 3. Early stage cervical cancer: Brachytherapy followed by type a hysterectomy versus type B radical hysterectomy alone, a retrospective evaluation.
    Lacorre A, Merlot B, Garabedian C, Narducci F, Chereau E, Resbeut M, Minsat M, Leblanc E, Houvenaeghel G, Lambaudie E.
    Eur J Surg Oncol; 2016 Mar; 42(3):376-82. PubMed ID: 26725307
    [Abstract] [Full Text] [Related]

  • 4. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M, Hentschel B, Horn LC.
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [Abstract] [Full Text] [Related]

  • 5. Class I versus class III radical hysterectomy in stage IB1-IIA cervical cancer. A prospective randomized study.
    Landoni F, Maneo A, Zapardiel I, Zanagnolo V, Mangioni C.
    Eur J Surg Oncol; 2012 Mar; 38(3):203-9. PubMed ID: 22244909
    [Abstract] [Full Text] [Related]

  • 6. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
    Rutledge TL, Kamelle SA, Tillmanns TD, Gould NS, Wright JD, Cohn DE, Herzog TJ, Rader JS, Gold MA, Johnson GA, Walker JL, Mannel RS, McMeekin DS.
    Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
    [Abstract] [Full Text] [Related]

  • 7. Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: a prospective randomized study.
    Landoni F, Maneo A, Cormio G, Perego P, Milani R, Caruso O, Mangioni C.
    Gynecol Oncol; 2001 Jan; 80(1):3-12. PubMed ID: 11136561
    [Abstract] [Full Text] [Related]

  • 8. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
    Gil-Moreno A, Puig O, Pérez-Benavente MA, Díaz B, Vergés R, De la Torre J, Martínez-Palones JM, Xercavins J.
    J Minim Invasive Gynecol; 2005 Jan; 12(2):113-20. PubMed ID: 15904613
    [Abstract] [Full Text] [Related]

  • 9. Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent.
    Narayan K, Fisher RJ, Bernshaw D.
    Int J Gynecol Cancer; 2008 Jan; 18(3):525-33. PubMed ID: 18476950
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Temporal pattern of recurrence of stage I endometrial cancer in relation to histological risk factors.
    Ben Arie A, Lavie O, Gdalevich M, Voldarsky M, Barak F, Schneider D, Levy T, Anteby E, Gemer O.
    Eur J Surg Oncol; 2012 Feb; 38(2):166-9. PubMed ID: 22056646
    [Abstract] [Full Text] [Related]

  • 12. Indicators of survival and prognostic factors in women treated for cervical cancer at a tertiary care center in Saudi Arabia.
    Anfinan N, Sait K.
    Ann Saudi Med; 2020 Feb; 40(1):25-35. PubMed ID: 32026705
    [Abstract] [Full Text] [Related]

  • 13. Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Paik ES, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, Suh DH, Lee JM, Lee C, Choi CH.
    Gynecol Oncol; 2019 Sep; 154(3):547-553. PubMed ID: 31272738
    [Abstract] [Full Text] [Related]

  • 14. Class III NSRH: oncological outcome in 170 cervical cancer patients.
    Ditto A, Martinelli F, Hanozet F, Reato C, Solima E, Zanaboni F, Grijuela B, Carcangiu M, Haeusler E, Raspagliesi F.
    Gynecol Oncol; 2010 Nov; 119(2):192-7. PubMed ID: 20719370
    [Abstract] [Full Text] [Related]

  • 15. Surgical, Urinary, and Survival Outcomes of Nerve-sparing Versus Traditional Radical Hysterectomy: A Retrospective Cohort Study in China.
    Li L, Ma S, Tan X, Zhong S, Wu M.
    Am J Clin Oncol; 2019 Oct; 42(10):783-788. PubMed ID: 31490195
    [Abstract] [Full Text] [Related]

  • 16. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Huang CY, Tang YH, Chiang YC, Wang KL, Fu HC, Ke YM, Lau HY, Hsu KF, Wu CH, Cheng WF.
    Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
    [Abstract] [Full Text] [Related]

  • 17. Effect of a T0 radical hysterectomy specimen on survival for early stage cervical cancer.
    Wright JD, Grigsby PW, Rader JS, Mutch DG, Powell MA, Gao F, Gibb RK.
    Gynecol Oncol; 2007 Nov; 107(2):280-4. PubMed ID: 17698175
    [Abstract] [Full Text] [Related]

  • 18. Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation.
    Hoskins PJ, Le N, Gilks B, Tinker A, Santos J, Wong F, Swenerton KD.
    J Clin Oncol; 2012 May 10; 30(14):1656-62. PubMed ID: 22493415
    [Abstract] [Full Text] [Related]

  • 19. Comparison of laparoscopic-assisted radical vaginal hysterectomy and laparoscopic radical hysterectomy in the treatment of cervical cancer.
    Choi CH, Lee JW, Lee YY, Kim HJ, Song T, Kim MK, Kim TJ, Kim BG, Bae DS.
    Ann Surg Oncol; 2012 Nov 10; 19(12):3839-48. PubMed ID: 22644508
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.